18beta-glycyrrhetinic acid carbamate derivative, preparation method and application thereof

An acid carbamate, glycyrrhetic acid technology, applied in the direction of drug combinations, steroids, antitumor drugs, etc., can solve the problem of unsatisfactory pharmacological activity, and achieve a new effect of compound structure

Inactive Publication Date: 2019-04-12
JINZHOU MEDICAL UNIV
View PDF0 Cites 2 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

Glycyrrhetinic acid derivatives can produce different degrees of antagonistic effects on human hepatocellular carcinoma, gastric cancer, breast cancer, lung cancer, rectal cancer, melanoma and other tumor cells through various mechanisms [Lallemand B, Gelbcke M, DuboisJ, et al .Mini Revi...

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Image

Smart Image Click on the blue labels to locate them in the text.
Viewing Examples
Smart Image
  • 18beta-glycyrrhetinic acid carbamate derivative, preparation method and application thereof
  • 18beta-glycyrrhetinic acid carbamate derivative, preparation method and application thereof
  • 18beta-glycyrrhetinic acid carbamate derivative, preparation method and application thereof

Examples

Experimental program
Comparison scheme
Effect test

Embodiment 1

[0043] The preparation method of 3β-(((3,4-dichlorophenyl)carbamoyl)oxy group)-11-oxo-olean-12-ene-29-acid (abbreviation: Ia) shown in the following structural formula , including the following steps:

[0044]

[0045] 18β-glycyrrhetinic acid (0.30mmol) and 3,4-dichlorophenylisocyanate (0.36mmol) were added to reflux reaction in ethyl acetate; after the reaction was completed, the mixture was concentrated under reduced pressure, and the resulting residue was passed through a column Purified by chromatography to obtain a white powdery solid with a yield of 78.1%; 1 H NMR(400MHz,Chloroform-d)δ7.63(s,1H,phenyl-H),7.33(d,J=8.7Hz,1H,phenyl-H),7.18(d,J=8.8Hz,1H,phenyl -H),6.71(s, 1H,N-H),5.70(s,1H,CH-12),4.50(dd,J=10.5,5.9Hz,1H,CH-3),2.87–2.77(m,1H, CH-1), 2.37(s,1H,CH-9), 2.18(dd,J=13.8,4.1Hz,1H,CH-16),2.06–1.00(m,17H), 1.37(s,3H,CH 3 -27),1.22(s,3H,CH 3 -25),1.16(s,3H,CH 3 -26),1.12(s,3H,CH 3 -29), 0.93(s,3H,CH 3 -23),0.87(s,3H,CH 3 -24),0.82(s,3H,CH 3 -28),0.80(d,1H,C...

Embodiment 2

[0047] 3β-(((4-chloro-3-(trifluoromethyl)phenyl)carbamoyl)oxy)-11-oxo-olean-12-en-29-acid (referred to as : the preparation method of Ib), comprising the steps of:

[0048]

[0049] 18β-glycyrrhetinic acid (0.30mmol) and 4-chloro-3-(trifluoromethyl)phenylisocyanate (0.36mmol) were added to reflux reaction in dichloromethane; after the reaction was over, the mixture was concentrated under reduced pressure, and The obtained residue was purified by column chromatography; a white powdery solid was obtained with a yield of 87.0%; 1 H NMR (400MHz, Chloroform-d) δ 7.76(s,1H,phenyl-H),7.54(s,1H,phenyl-H),7.40(d,J=8.7Hz,1H,phenyl-H),6.83( s, 1H, N-H), 5.70(s, 1H, CH-12), 4.56–4.47(m, 1H, CH-3), 2.82(d, J=13.6Hz, 1H, CH-1), 2.37(s ,1H,CH-9),2.17(d,J=11.9Hz,1H,CH-16),2.06–1.00(m,17H),1.37(s,3H,CH 3 -27),1.22(s,3H,CH 3 -25),1.16(s,3H,CH 3 -26),1.12(s,3H,CH 3 -29),0.94(s,3H,CH 3 -23),0.88(s,3H,CH 3 -24),0.82(s,3H,CH 3 -28),0.80(d,1H,CH-5); HRMS(m / z):[M +H] + calcd.ForC 38 h ...

Embodiment 3

[0051] The preparation method of 3β-(((3,5-dichlorophenyl)carbamoyl)oxy)-11-oxo-olean-12-ene-29-acid (abbreviation: Ic) as shown in the following structural formula , including the following steps:

[0052]

[0053] 18β-glycyrrhetinic acid (0.30mmol) and 3,5-dichlorophenylisocyanate (0.36mmol) were added to reflux reaction in chloroform; after the reaction was completed, the mixture was concentrated under reduced pressure, and the resulting residue was passed through a column Purified by chromatography to obtain a white powdery solid with a yield of 78.1%; 1 H NMR (400MHz, Chloroform-d) δ7.35(s, 2H, phenyl-H), 7.02(t, J=1.8Hz, 1H, phenyl-H), 6.62(s, 1H, N-H), 5.69(s ,1H,CH-12),4.50 (dd,J=10.7,5.7Hz,1H,CH-3),2.82(d,J=13.2Hz,1H,CH-1),2.37(s,1H,CH- 9), 2.17 (d, J=11.9Hz, 1H, CH-16), 2.03–0.83 (m, 17H), 1.37 (s, 3H, CH 3 -27),1.22(s,3H,CH 3 -25),1.16(s,3H,CH 3 -26),1.12(s,3H,CH 3 -29),0.94(s,3H,CH 3 -23),0.88(s,3H,CH 3 -24),0.82(s,3H,CH 3 -28),0.79–0.73(m,1H,CH-5); HRM...

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to view more

PUM

No PUM Login to view more

Abstract

The invention discloses a 18beta-glycyrrhetinic acid carbamate derivative, which has a structure shown as formula (I) or (II) in the specification. The compound provided by the invention has a brand new structure, and has significant inhibitory effect on lung cancer, liver cancer, colon cancer, breast cancer and prostate cancer cell lines. And the antitumor activity of parts of the compounds is close to crizotinib.

Description

technical field [0001] The invention belongs to the field of medicinal chemistry, and in particular relates to a 18β-glycyrrhetinic acid carbamate derivative and a preparation method and application thereof. Background technique [0002] Most of the triterpene acid compounds are tetracyclic triterpene acid and pentacyclic triterpene acid, among which pentacyclic triterpene acid components are more common in medicinal plants and can be divided into four types in terms of structure, namely ursane type, Argan type, lupine type and suberane type. Glycyrrhetinic acid (glycyrrhetinic acid, GA) belongs to pentacyclic triterpenoids, and there is C=O at the 11th position of the skeleton, which is similar to the 18-H-oleanane structure. [0003] There are different optical isomers in the structure of glycyrrhetinic acid, such as 18α and 18β, and the pharmacological effects of these isomers are not completely the same. Among them, 18α-glycyrrhetinic acid is better in liver targeting a...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to view more

Application Information

Patent Timeline
no application Login to view more
IPC IPC(8): C07J63/00A61P35/00
CPCA61P35/00C07J63/008
Inventor 蔡东孙玉琦杨殿深宫益霞贾云宏
Owner JINZHOU MEDICAL UNIV
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Try Eureka
PatSnap group products